CPhI Worldwide Postponed until 2021
New virtual event ‘CPhI: Festival of Pharma’ introduced

Following discussions with key partners and industry stakeholders, the CPhI Worldwide in-person event is now confirmed to return in 2021, with the 2020 edition in Milan not taking place.

Responding to the need to connect + collaborate in today’s pharmaceutical industry, CPhI is excited to present you with the CPhI: Festival of Pharma, a new virtual extravaganza for the global pharma community.

From 5 – 16 October 2020, the CPhI: Festival of Pharma will combine the world’s leading pharma companies, incredible speakers and unparalleled networking opportunities, all of it under the most advanced digital ecosystem.

CPhI Worldwide houses six zones representing each stage of the pharmaceutical supply chain - from APIs, machinery and packaging to outsourcing and biopharmaceuticals. Uniting tens of thousands of visitors and thousands of international exhibitors, this is the place to network and source cost-effective pharma solutions from all continents - in 3 days, under one roof.

The world's largest pharmaceutical exhibition, CPhI Worldwide houses 6 individual pharma events covering all industry sectors:

  • Unlimited networking opportunities
  • 170+ countries participating
  • 2,500+ exhibiting companies

“When you say everything under one roof, you can actually come (to CPhI Worldwide) and see what everything under one roof means. The idea of this event is to touch base, to make deeper connections with the connections that I already have and to find new business. It's extremely important!”

Global Pharma Insights is a new dedicated platform providing news, features, interviews and in-depth analysis on issues impacting pharmaceutical supply chains. From drug discovery and development to manufacturing and delivery, we bring you impactful content to keep you informed and help drive your business forward.

The CPhI Pharma Awards are going digital!

The Awards will be livestreamed on 13th of October, and recognise the innovation and dedication of companies and individuals who are driving the pharmaceutical industry forward. They are open for entries to all pharma and biopharma companies engaged in the design, development, manufacture, production and distribution of large and small molecule drug products.